214 related articles for article (PubMed ID: 27986088)
1. Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein.
Ahmad A; Javed MR; Rao AQ; Husnain T
BMC Complement Altern Med; 2016 Dec; 16(1):519. PubMed ID: 27986088
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking based screening of neem-derived compounds with the NS1 protein of Influenza virus.
Ahmad A; Ahad A; Rao AQ; Husnain T
Bioinformation; 2015; 11(7):359-65. PubMed ID: 26339153
[TBL] [Abstract][Full Text] [Related]
3. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
Davis AM; Ramirez J; Newcomb LL
Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
[TBL] [Abstract][Full Text] [Related]
4. From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus.
Dilly S; Fotso Fotso A; Lejal N; Zedda G; Chebbo M; Rahman F; Companys S; Bertrand HC; Vidic J; Noiray M; Alessi MC; Tarus B; Quideau S; Riteau B; Slama-Schwok A
J Med Chem; 2018 Aug; 61(16):7202-7217. PubMed ID: 30028133
[TBL] [Abstract][Full Text] [Related]
5. Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.
Liu CL; Hung HC; Lo SC; Chiang CH; Chen IJ; Hsu JT; Hou MH
Sci Rep; 2016 Feb; 6():21662. PubMed ID: 26916998
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
Hagiwara K; Kondoh Y; Ueda A; Yamada K; Goto H; Watanabe T; Nakata T; Osada H; Aida Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):721-7. PubMed ID: 20230782
[TBL] [Abstract][Full Text] [Related]
7. Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.
Hu Y; Sneyd H; Dekant R; Wang J
Curr Top Med Chem; 2017; 17(20):2271-2285. PubMed ID: 28240183
[TBL] [Abstract][Full Text] [Related]
8. A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
Kakisaka M; Sasaki Y; Yamada K; Kondoh Y; Hikono H; Osada H; Tomii K; Saito T; Aida Y
PLoS Pathog; 2015 Jul; 11(7):e1005062. PubMed ID: 26222066
[TBL] [Abstract][Full Text] [Related]
9. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput screening system targeting the nuclear export pathway via the third nuclear export signal of influenza A virus nucleoprotein.
Kakisaka M; Mano T; Aida Y
Virus Res; 2016 Jun; 217():23-31. PubMed ID: 26948263
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.
Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G
J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684
[TBL] [Abstract][Full Text] [Related]
12. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA.
Ye Q; Krug RM; Tao YJ
Nature; 2006 Dec; 444(7122):1078-82. PubMed ID: 17151603
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus.
Tarus B; Bertrand H; Zedda G; Di Primo C; Quideau S; Slama-Schwok A
J Biomol Struct Dyn; 2015 Sep; 33(9):1899-912. PubMed ID: 25333630
[TBL] [Abstract][Full Text] [Related]
14. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin.
Stoppani E; Bassi I; Dotti S; Lizier M; Ferrari M; Lucchini F
Antiviral Res; 2015 Aug; 120():16-22. PubMed ID: 25986248
[TBL] [Abstract][Full Text] [Related]
15. Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target.
Babar MM; Zaidi NU
Infect Genet Evol; 2015 Aug; 34():200-10. PubMed ID: 26140959
[TBL] [Abstract][Full Text] [Related]
16. Structure and sequence analysis of influenza A virus nucleoprotein.
Ng AK; Wang JH; Shaw PC
Sci China C Life Sci; 2009 May; 52(5):439-49. PubMed ID: 19471866
[TBL] [Abstract][Full Text] [Related]
17. Disrupting the Conserved Salt Bridge in the Trimerization of Influenza A Nucleoprotein.
Woodring JL; Lu SH; Krasnova L; Wang SC; Chen JB; Chou CC; Huang YC; Cheng TR; Wu YT; Chen YH; Fang JM; Tsai MD; Wong CH
J Med Chem; 2020 Jan; 63(1):205-215. PubMed ID: 31769665
[TBL] [Abstract][Full Text] [Related]
18. [Development of anti-influenza drug].
Zhang T; Wang CY; Gao YW; Yang ST; Wang TC; Xia XZ
Bing Du Xue Bao; 2011 Sep; 27(5):475-80. PubMed ID: 21998961
[No Abstract] [Full Text] [Related]
19. Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target.
Chenavas S; Crépin T; Delmas B; Ruigrok RW; Slama-Schwok A
Future Microbiol; 2013 Dec; 8(12):1537-45. PubMed ID: 24266354
[TBL] [Abstract][Full Text] [Related]
20. Synergy of two low-affinity NLSs determines the high avidity of influenza A virus nucleoprotein NP for human importin α isoforms.
Wu W; Sankhala RS; Florio TJ; Zhou L; Nguyen NLT; Lokareddy RK; Cingolani G; Panté N
Sci Rep; 2017 Sep; 7(1):11381. PubMed ID: 28900157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
